Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.

about

Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.

Item

http://www.wikidata.org/entity/Q40141454

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation the Architect EBV V ...... ostatus prior transplantation.

@en

type

Item

label

Evaluation the Architect EBV V ...... ostatus prior transplantation.

@en

prefLabel

Evaluation the Architect EBV V ...... ostatus prior transplantation.

@en

P1476

Evaluation the Architect EBV V ...... rostatus prior transplantation

@en

P2093

Adel Herda

http://www.w3.org/2001/XMLSchema#string

François Simon

http://www.w3.org/2001/XMLSchema#string

Linda Feghoul

http://www.w3.org/2001/XMLSchema#string

Maud Salmona

http://www.w3.org/2001/XMLSchema#string

Séverine Mercier-Delarue

http://www.w3.org/2001/XMLSchema#string

P2860

Serological diagnosis of Epstein-Barr virus infection: Problems and solutions

Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluoresc

Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.

Epstein-Barr virus and cancer.

Umbilical cord blood transplantation: the first 25 years and beyond.

Infectious mononucleosis and Epstein-Barr virus.

Risk evaluation and mitigation strategies: a focus on belatacept.

Risk of posttransplant lymphoproliferative disorder associated with use of belatacept.

Assessment of rapid ELISA test for detection of Epstein-Barr virus infection.

Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.

P304

2003-2010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jerome LeGoff

Sarah Maylin

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28661055

http://www.w3.org/2001/XMLSchema#string